Nisa Investment Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,830
Closed -$26K 2897
2023
Q1
$26K Sell
22,830
-104,327
-82% -$191K ﹤0.01% 1931
2022
Q4
$341K Buy
127,157
+47,327
+59% +$125K ﹤0.01% 1228
2022
Q3
$152K Buy
79,830
+75,000
+1,553% +$319K ﹤0.01% 1349
2022
Q2
$24K Buy
4,830
+1,600
+50% +$8.38K ﹤0.01% 2001
2022
Q1
$23K Buy
+3,230
New +$26.7K ﹤0.01% 2028
2021
Q4
Sell
-560
Closed -$11 2348
2021
Q3
$11 Hold
560
﹤0.01% 2196
2021
Q2
$25 Buy
+560
New +$26K ﹤0.01% 2097

Other funds holding CELL

Nisa Investment Advisors's CELL Position: Q2 2023 in Review

Nisa Investment Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 22,830 shares — an estimated $26K sold.

Nisa Investment Advisors first reported a position in CELL in Q2 2021 and held it in 7 quarters. The position peaked at $341K in Q4 2022. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Nisa Investment Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 22,830 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $26K.
  • Nisa Investment Advisors first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Nisa Investment Advisors's PhenomeX Inc. Common Stock position peaked at $341K in Q4 2022.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Nisa Investment Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.